Sensient Technologies
SXT
113.85
-2.58
-2.22%
Sensient Technologies
US · SXT
#2027 by market cap
Listed 1970
113.85
-2.58
-2.22%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 14 in the most recent period (2026/Q3).
- Total institutional ownership fell 6.2 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 94.75% -6.23pp
- Institutions
- 449 +14
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund77.93%
Hedge Fund10.94%
Public Company2.41%
Individual/Insider1.58%
Government Pension Fund1.33%
Sovereign Wealth Fund1.17%
Private Company0.43%
Insurance Company0.41%
Other3.72%
Top holders as of 2026-09-30
BlackRock
15.28% · 6.50M sh
Vanguard Portfolio Management, LLC
6.53% · 2.78M sh
Vanguard Capital Management, LLC
4.50% · 1.92M sh
Janus Henderson Group plc
4.03% · 1.71M sh
Freemont Capital Pte. Ltd.
4.82% · 2.05M sh
State Street Global Advisors
4.01% · 1.71M sh
Geode Capital Management, LLC
2.51% · 1.07M sh
Dimensional Fund Advisors
2.41% · 1.02M sh
American Century Investment Management
2.22% · 946.15K sh
Congress Asset Management Company, LLP
2.19% · 932.08K sh
Vaughan Nelson Investment Management, L.P.
2.37% · 1.01M sh
Westwood Management Corp.
2.08% · 884.34K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Paul Manning | Chairman, CEO, President & Member of Scientific Advisory Committee | 0.66% |
| Stephen Rolfs | Former Senior Vice President | 0.32% |
| Michael Geraghty | Member of Scientific Advisory Committee | 0.11% |
| John Manning | Senior Vice President | 0.09% |
| Amy Jones | VP of Human Resources & Senior Counsel | 0.06% |
| Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | 0.06% |
| Deborah McKeithan-Gebhardt | Former Independent Director & Member of Scientific Advisory Committee | 0.05% |
| Tobin Tornehl | Vice President | 0.04% |
| Essie Whitelaw | Director & Member of Scientific Advisory Committee | 0.04% |
| Thierry Hoang | -- | 0.03% |
| Scott Morrison | Independent Director & Member of Scientific Advisory Committee | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +279 | -- |
| 2026-09-29 | Mario Ferruzzi | Independent Director & Chairman of Scientific Advisory Committee | Other Derivative Acquisition | +42 | -- |
| 2026-08-04 | Mario Ferruzzi | Independent Director & Chairman of Scientific Advisory Committee | Open Market Disposition | -1,200 | $129.48 |
| 2026-06-30 | Chandrabhushan Singh | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-06-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +296 | -- |
| 2026-06-29 | Mario Ferruzzi | Independent Director & Chairman of Scientific Advisory Committee | Other Derivative Acquisition | +44 | -- |
| 2026-05-17 | Thierry Hoang | -- | Open Market Disposition | -400 | $115.19 |
| 2026-05-03 | Thierry Hoang | -- | Open Market Disposition | -439 | $114.15 |
| 2026-04-29 | Freemont Capital Pte. Ltd. | -- | Open Market Disposition | -2,127,566 | $109.69 |
| 2026-04-29 | Steve Morris | President of Color Group | Open Market Disposition | -200 | $114.58 |
| 2026-04-22 | Essie Whitelaw | Former Independent Director | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Essie Whitelaw | Former Independent Director | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Mario Ferruzzi | Independent Director & Chairman of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Sensient Technologies discussion 0 comments